Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA.

Bladder cancer Proliferating cell nuclear antigen (PCNA) RNA-seq Squalene monooxygenase (SQLE)

Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 02 06 2023
revised: 05 01 2024
accepted: 18 01 2024
medline: 28 1 2024
pubmed: 28 1 2024
entrez: 27 1 2024
Statut: aheadofprint

Résumé

Bladder cancer (BC) is one of the most common cancers worldwide. Although the treatment and survival rate of BC are being improved, the risk factors and the underlying mechanisms causing BC are incompletely understood. Squalene monooxygenase (SQLE) has been associated with the occurrence and development of multiple cancers but whether it contributes to BC development is unclear. In this study, we performed bioinformatics analysis on paired BC and adjacent non-cancerous tissues and found that SQLE expression is significantly upregulated in BC samples. Knockdown of SQLE impairs viability, induces apoptosis, and inhibits the migration and invasion of BC cells. RNA-seq data reveals that SQLE deficiency leads to dysregulated expression of genes regulating proliferation, migration, and apoptosis. Mass spectrometry-directed interactome screening identifies proliferating cell nuclear antigen (PCNA) as an SQLE-interacting protein and overexpression of PCNA partially rescues the impaired viability, migration, and invasion of BC cells caused by SQLE knockdown. In addition, we performed xenograft assays and confirmed that SQLE deficiency inhibits BC growth in vivo. In conclusion, these data suggest that SQLE promotes BC development and SQLE inhibition may be therapeutically useful in BC treatment.

Identifiants

pubmed: 38280406
pii: S0167-4889(24)00024-7
doi: 10.1016/j.bbamcr.2024.119681
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119681

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Changyan Zhu (C)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China.

Xiao Fang (X)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China; Department of Urology, MengChao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China.

Xiangshen Liu (X)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China.

Chengxi Jiang (C)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China.

Wenjun Ren (W)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China.

Wenmao Huang (W)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China.

Yanyan Jiang (Y)

Department of Ultrasonography, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China. Electronic address: 1398135005@qq.com.

Dong Wang (D)

Department of Urology, Fuzong clinical medical college of Fujian Medical University, Fuzhou 350025, China. Electronic address: dongwang_2017@163.com.

Classifications MeSH